The clinical impact of screening for gestational diabetes

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 9, 2004, Pages 1036-1042

  Schytte, Tine ^a   Jørgensen, Lone G M ^a   Brandslund, Ivan ^a   Petersen, Per Hyltoft ^b,c   Andersen, Bent ^a  

^a LILLEBAELT HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

Gestational diabetes; Pregnancy; Screening

Indexed keywords

CARBOHYDRATE;

ADULT; AGE; ARTICLE; BODY MASS; CARBOHYDRATE INTOLERANCE; CONTROLLED STUDY; DENMARK; DIET RESTRICTION; FEMALE; FREQUENCY ANALYSIS; GLUCOSE BLOOD LEVEL; GLUCOSURIA; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; OUTCOMES RESEARCH; PREDICTION; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; RISK FACTOR; SCREENING TEST; SENSITIVITY ANALYSIS; URINALYSIS;

ADULT; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 4744355705     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.209     Document Type: Article

References (31)

1. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998;21Suppl:5-19.
2. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 1998;21Suppl1:60-1.
3. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: WHO 1999 (WHO/NCD/NCS/99.2)
4. U.S. Preventive Service Task Force. Screening for gestational diabetes mellitus: recommendations and rationale. Obstet Gynecol 2003;101:393-5.
5. Gabbe SG. Gestational diabetes. N Engl J Med 1986;315:1025-6.
6. O'Sullivan JB, Mahan C, Charles D, Danson R. Screening criteria for high risk gestational diabetic patients. Am J Obstet Gynecol 1973;116:895-900.
7. O'Sullivan JB, Charles D, Mahan C. Gestational diabetes and perinatal mortality rate. Am J Obstet Gynecol 1973;116:901-4.
8. Pettitt DJ, Knowler WC, Baird HR, Bennett PH. Gestational diabetes: infant and maternal complications of pregnancy in relation to third trimester glucose tolerance in the Pima Indians. Diabetes Care 1980;3:458-64.
9. Jensen DM, Damm P, Sørensen B, Mølsted-Pedersen L, Westergaard JG, Korsholm L, et al. Proposed diagnostic thresholds for gestational diabetes mellitus according to a 75-g oral glucose tolerance test. Maternal and perinatal outcomes in 3260 Danish women. Diabet Med 2003;20:51-7.
10. Kaufmann RC, Smith T, Bochantin T, Khardori R, Evans MS, Steahly L. Failure to obtain follow-up testing for gestational diabetic patients in a rural population. Am J Obstet Gynecol 1999;93:734-7.
11. Jovanovic-Peterson L, Peterson CM. Rationale for prevention and treatment of glucose-mediated macrosomia: a protocol for gestational diabetes. Endocrinol Pract 1996;2:118-29.
12. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-44.
13. Danish National Board of Health. Svangreomsorg, retningslinier og redegørelse. Sundhedsstyrelsen 1998.
14. Åberg A, Rydhström H, Källen B, Källen K. Impaired glucose tolerance during pregnancy is associated with increased fetal mortality in preceding sibs. ACTA Obstet Gynechol Scand 1997;76:212-17.
15. Lind T. Antenatal screening using random blood glucose values. Diabetes 1985;34:Suppl 2:17.
16. Kuhl C. Glucose metabolism during and after pregnancy in normal and gestational diabetic women. Influence of normal pregnancy on serum glucose and insulin concentration during basal fasting conditions and after a challenge with glucose. Acta Endocrinol Copenh 1975;79:709-19.
17. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768-73.
18. Moses R, Webb AJ, Lucas EM, Davis WS. Twin pregnancy outcome for women with gestational diabetes mellitus compared with glucose tolerant women. Aust N Z J Obstet Gynaecol 2003;43:38-40
19. Banauch D, Brummer W, Ebeling W, Metz H, Rindfrey H, Lang H, et al. Eine Glucose-Dehydrogenase für die Glucosebestimmung in Korperflüssigkeiten. Z Klin Chem Klin Biochem 1975;13:101-7.
20. Stahl M, Brandslund I, Iversen S, Filtenborg JA. Quality assessment of blood glucose testing in general practitioners' office improves quality. Clin Chem 1997;43:1926-31.
21. Morishima HO. Virginia Apgar (1909-1974). J Pediatr 1996;129:768-70.
22. Gardner MJ, Altman DG. Calculating confidence intervals for proportions and their differences. In: Gardner MJ, Altman DG, editors. Statistics with confidence. Confidence intervals and statistical guidelines. London: BMJ Books, 1992.
23. European Diabetes Policy Group 1999. A desktop guide to type 2 diabetes mellitus. Diab Med 1999;16:716-30. (http://www.staff.ncl.ac.uk/philip.home/guidelines).
24. Jørgensen LGM, Schytte T, Brandslund I, Stahl M, Hyltoft Petersen P, Andersen B. The fasting and post glucose load reference limit of peripheral venous plasma glucose in pregnant women Clin Chem Lab Med 2003;41:187-99.
25. Sacks DA, Chen W, Wolde-Tsadik G, Buchanan TA. Fasting plasma glucose test at the first prenatal visit as a screen for gestational diabetes. Obstet Gynecol 2003;101:1197-203.
26. Westerway SC, Keogh J, Heard R, Morris J. Incidence of fetal macrosomia and birth complications in Chinese immigrant women. Aus N Z J Obstet Gynaecol 2003;43:46-9.
27. Wagaarachchi PT, Fernando L, Premachadra P, Fernando JS. Screening based on risk factors for gestational diabetes in an Asian population. J Obstet Gynecol 2001;21:32-4.
28. Brody SC, Harris R, Lohr K. Screening for gestational diabetes: a summary of the evidence for the US preventive service task force. Obstet Gynecol 2003;101:380-92.
29. Stahl M, Jørgensen LGM, Hyltoft Petersen P, Brandslund I, de Fine Olivarius N, Borch-Johnsen K. Optimization of preanalytical conditions and analysis of plasma glucose. 1. The impact of the new WHO and ADA recommendations on the diagnosis of diabetes mellitus. Scand J Clin Lab Invest 2001;61:169-80.
30. Jørgensen LGM, Stahl M, Brandslund I, Hyltoft Petersen P, Borch-Johnsen K, de Fine Olivarius N. The plasma glucose reference interval in a low-risk population. 2. The impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus. Scand J Clin Lab Invest 2001;61:181-90.
31. Hyltoft Petersen P, Brandslund I, Jorgensen LGM, Stahl M, de Fine Olivarius N, Borch-Johnsen K. Evaluation of systematic and random factors in measurements of fasting plasma glucose as basis for analytical quality specifications for the diagnosis of diabetes. 3. The impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus diabetes. Scand J Clin Lab Invest 2001;61:191-204.